Globally,Porcine circovirustype 2 (PCV2) is a recognized viral pathogen of great economic value in pig farming. It is the major cause of ravaging postweaning multisystemic wasting syndrome (PMWS) and many other disease syndromes generally regarded asPorcine circovirusassociated diseases (PCVAD) in Europe. PCV2 infections, specifically PMWS, had impacted huge economic loss on swine production at different regions of the world. It has been studied and reported at different parts of the globe including: North and South America, Europe, Asia, Oceania, Middle East, and the Caribbean. However, till date, this virus and its associated diseases have been grossly understudied in sub-Sahara African region and the entire continent at large. Two out of forty-nine, representing just about 4% of countries that make up sub-Sahara Africa presently, have limited records on reported cases and occurrence of the viral pathogen despite the ubiquitous nature of the virus. This review presents an overview of the discovery ofPorcine circovirusand its associated diseases in global pig herds and emphasizes the latest trends in PCV2 vaccines and antiviral drugs development and the information gaps that exist on the occurrence of this important viral pathogen in swine herds of sub-Saharan Africa countries. This will serve as wake-up call for immediate and relevant actions by stakeholders in the region.

The classical porcine parvovirus is an important pathogen of reproductive disorders in pigs with a confirmed history of global distribution. The detection of many novel porcine parvoviruses has however been on the increase for the past few years, but there is a dearth of information on the occurrence and prevalence of these viruses in South Africa. Molecular detection of some known parvoviruses, namely porcine parvoviruses (PPVs) - 1, 2, 3 and 4, porcine bocavirus-like virus (PBo-likeV) and porcine bocaviruses (PBoV1/2), was carried out from 110 randomly selected archived swine samples collected in the year 2015 and 2016. Samples were drawn from previously screened and confirmed porcine circovirus type 2 (PCV2) infected farms, with farm-level occurrence ranged from 5.6 to 60%. The findings showed that all the screened parvoviruses were present as follows: PPV1 (29.1%), PPV2 (21.8%), PPV3 (5.5%), PPV4 (43.6%), PBo-likeV (21.8%) and PBoV1/2 (44.6%). The frequency of double infections of the viruses was as high as 18.2% of PPV2/PPV4 and PPV4/PBoVs; while 17.3% and 7.3% of the screened samples showed multiple infections of the three and four viruses respectively. Further phylogenetic analyses of partial PPV1, 2 and PBoV1/2 sequences showed two major clades for each of the viruses. This study reports the first epidemiological survey and molecular characterisation of the classical and emerging porcine parvoviruses in South African swine herds. It also gives insights into the diversity and distribution of these viral pathogens within the herds of the study area and confirms their co-infection potentials with PCV2.

Detection of infectious viral agents has been on the increase globally with the advent and usage of more sensitive and selective novel molecular techniques in the epidemiological study of viral diseases of economic importance to the swine industry. The observation is not different for the pig-infecting member of the subfamily Parvovirinae in the family Parvoviridae as the application of novel molecular methods like metagenomics has brought about the detection of many other novel members of the group. Surprisingly, the list keeps increasing day by day with some of them possessing zoonotic potentials. In the last one decade, not less than ten novel swine-infecting viruses have been added to the subfamily, and ceaseless efforts have been in top gear to determine the occurrence and prevalence of the old and new swine parvoviruses in herds of pig-producing countries worldwide. The story, however, is on the contrary on the African continent as there is presently a dearth of information on surveillance initiatives of the viruses among swine herds of pig-producing countries in the region. Timely detection and characterization of the viral pathogens is highly imperative for the implementation of effective control and prevention of its spread. This review therefore presents a concise overview on the epidemiology of novel porcine parvoviruses globally and also provides up-to-date highlights on the reported cases of the viral agents in the African sub-region.

Porcine circovirus type 2 (PCV2) remains the main causative viral pathogen of porcine circovirus-associated diseases (PCVAD) of great economic importance in pig industry globally. This present study aims at determining the occurrence of the viral pathogen in swine herds of the Province. The data obtained revealed that 15.93% of the screened samples (54/339) from the swine herds of the studied areas were positive for PCV2; while the severity of occurrence of the viral pathogen as observed at farm level ranges from approximately 5.6 to 60% in the studied farms. The majority (15 out of 17 = 88%) of the analyzed sequences were found clustering with other PCV2b strains in the phylogenetic analysis. More interestingly, two other sequences obtained were also found clustering within PCV2d genogroup, which is presently another fast-spreading genotype with observable higher virulence in global swine herds. This is the first report of PCV2 in swine herds of the Province and the first detection of PCV2b and PCV2d in South African swine herds. It follows the first reported case of PCV2a in an outbreak of porcine multisystemic wasting syndrome (PMWS) in Gauteng Province, South Africa more than one decade ago. This finding confirmed the presence of this all-important viral pathogen in pigs of the region; which could result in a serious outbreak of PCVAD and huge economic loss at the instances of triggering factors if no appropriate measures are taken to effectively curb its spread.

Enterococcus spp. are common but not predominant commensal bacteria that inhabit the gastrointestinal tracts of humans and animals and are widely distributed in various environmental matrices and diverse food sources. Multiple strains of beneficial enterococci are increasingly utilized as protective cultures, alternatives to antibiotics, and probiotics for controlling pathogens, mitigating disease, modulating the microbiome, and supporting overall host health. They also support food fermentation and safety, enhance sensory properties, and produce bioactive compounds such as bacteriocins with strong pathogen-inhibitory activity and multifarious health benefits. Despite their advantages in health and agrifood systems, their association with healthcare-associated infections and the spread of antimicrobial resistance raises concerns about their safety. These risks underscore the need for stringent safety evaluations before their use as probiotics, alternatives to antibiotics, or protective cultures. Here, we provide a comprehensive atlas of the multifaceted probiotic and antimicrobial potential, as well as safety considerations of beneficial enterococci. This would provide a valuable resource for future research, regulatory assessments, and applications in the agrifood system and healthcare.